Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Clinical practice guideline for renal hypouricemia (1st edition).

Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N.

Hum Cell. 2019 Apr;32(2):83-87. doi: 10.1007/s13577-019-00239-3. Epub 2019 Feb 19. Review.

2.

Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in Japan.

Hakoda M, Kasagi F.

Mod Rheumatol. 2018 Oct 5:1-5. doi: 10.1080/14397595.2018.1519149. [Epub ahead of print]

PMID:
30175646
3.

Development of dielectrophoresis separator with an insulating porous membrane using DC-Offset AC Electric Fields.

Hakoda M.

Biotechnol Prog. 2016 Sep;32(5):1292-1300. doi: 10.1002/btpr.2330. Epub 2016 Aug 3.

PMID:
27453404
4.

Metabolic Profile as a Potential Modifier of Long-Term Radiation Effects on Peripheral Lymphocyte Subsets in Atomic Bomb Survivors.

Yoshida K, Nakashima E, Kyoizumi S, Hakoda M, Hayashi T, Hida A, Ohishi W, Kusunoki Y.

Radiat Res. 2016 Sep;186(3):275-82. doi: 10.1667/RR14336.1. Epub 2016 Aug 19.

PMID:
27541825
5.

Correlation between dielectric property by dielectrophoretic levitation and growth activity of cells exposed to electric field.

Hakoda M, Hirota Y.

Bioprocess Biosyst Eng. 2013 Sep;36(9):1219-27. doi: 10.1007/s00449-012-0849-3. Epub 2012 Nov 20.

6.

Recent trends in hyperuricemia and gout in Japan.

Hakoda M.

Japan Med Assoc J. 2012 Jul;55(4):319-23. Review.

PMID:
25237240
7.

Molecular characterization of a deletion in the HPRT1 gene in a patient with Lesch-Nyhan syndrome.

Taniguchi A, Yamada Y, Hakoda M, Sekita C, Kawamoto M, Kaneko H, Yamanaka H.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1266-71. doi: 10.1080/15257770.2011.608396.

PMID:
22132985
8.

Lymphocyte subset characterization associated with persistent hepatitis C virus infection and subsequent progression of liver fibrosis.

Yoshida K, Ohishi W, Nakashima E, Fujiwara S, Akahoshi M, Kasagi F, Chayama K, Hakoda M, Kyoizumi S, Nakachi K, Hayashi T, Kusunoki Y.

Hum Immunol. 2011 Oct;72(10):821-6. doi: 10.1016/j.humimm.2011.05.029. Epub 2011 Jun 15.

PMID:
21712057
9.

Urine alkalization facilitates uric acid excretion.

Kanbara A, Hakoda M, Seyama I.

Nutr J. 2010 Oct 19;9:45. doi: 10.1186/1475-2891-9-45.

10.

Separation of viable and nonviable animal cell using dielectrophoretic filter.

Hakoda M, Wakizaka Y, Hirota Y.

Biotechnol Prog. 2010 Jul-Aug;26(4):1061-7. doi: 10.1002/btpr.394.

PMID:
20205163
11.

Separation characteristics of animal cells using a dielectrophoretic filter.

Hirota Y, Hakoda M, Wakizaka Y.

Bioprocess Biosyst Eng. 2010 Jun;33(5):607-12. doi: 10.1007/s00449-009-0382-1. Epub 2009 Oct 17.

PMID:
19838737
12.

Combining effects of polymorphism of tumor necrosis factor α 5'-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis.

Ichikawa N, Kotake S, Hakoda M, Higami K, Kawasaki A, Furuya T, Nanke Y, Tsuchiya N, Tokunaga K, Kamatani N.

Mod Rheumatol. 2009 Apr;19(2):134-139. doi: 10.3109/s10165-008-0134-0.

PMID:
28925311
13.

Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis.

Furuya T, Matsumoto I, Tsuchiya N, Hakoda M, Ichikawa N, Yago T, Higami K, Nanke Y, Sumida T, Kamatani N, Kotake S.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):918-21.

PMID:
19032829
14.

Combining effects of polymorphism of tumor necrosis factor alpha 5'-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis.

Ichikawa N, Kotake S, Hakoda M, Higami K, Kawasaki A, Furuya T, Nanke Y, Tsuchiya N, Tokunaga K, Kamatani N.

Mod Rheumatol. 2009;19(2):134-9. doi: 10.1007/s10165-008-0134-0. Epub 2008 Nov 12.

PMID:
19002558
15.

[Epidemiology of hyperuricemia and gout in Japan].

Hakoda M.

Nihon Rinsho. 2008 Apr;66(4):647-52. Review. Japanese.

PMID:
18409509
16.

Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.

Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kamatani N, Kotake S.

Clin Rheumatol. 2007 Dec;26(12):2137-2141. doi: 10.1007/s10067-007-0745-4. Epub 2007 Sep 18.

PMID:
17876645
17.

[Absolute risk for fracture and WHO guideline. Epidemiology of rheumatoid arthritis].

Hakoda M; World Health Organization.

Clin Calcium. 2007 Jul;17(7):1081-7. Review. Japanese.

PMID:
17607076
18.

Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.

Suzuki G, Cullings H, Fujiwara S, Hattori N, Matsuura S, Hakoda M, Akahoshi M, Kodama K, Tahara E.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1224-8.

19.

Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.

Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kobashigawa T, Tokunaga K, Tsuchiya N, Kamatani N, Kotake S.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):219-24.

PMID:
17543145
20.

Rational method for designing efficient separations by chromatography on polystyrene-divinylbenzene resins eluted with aqueous ethanol.

Yamamoto S, Hakoda M, Oda T, Hosono M.

J Chromatogr A. 2007 Aug 24;1162(1):50-5. Epub 2007 Apr 19.

PMID:
17498724
21.

Feasibility of freeze-dried sera for serological and molecular biological detection of hepatitis B and C viruses.

Ohishi W, Fujiwara S, Suzuki G, Kishi T, Sora M, Matsuura S, Hakoda M, Tatsukawa Y, Yamada M, Chayama K.

J Clin Microbiol. 2006 Dec;44(12):4593-5. Epub 2006 Oct 11.

22.

Levels of antibodies to microorganisms implicated in atherosclerosis and of C-reactive protein among atomic bomb survivors.

Hakoda M, Kasagi F, Kusunoki Y, Matsuura S, Hayashi T, Kyoizumi S, Akahoshi M, Suzuki G, Kodama K, Fujiwara S.

Radiat Res. 2006 Aug;166(2):360-6.

PMID:
16881737
23.

Development of a method to analyze single cell activity by using dielectrophoretic levitation.

Hakoda M, Hachisu T, Wakizaka Y, Mii S, Kitajima N.

Biotechnol Prog. 2005 Nov-Dec;21(6):1748-53.

PMID:
16321061
24.
25.

Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study.

Hakoda M, Oiwa H, Kasagi F, Masunari N, Yamada M, Suzuki G, Fujiwara S.

Ann Rheum Dis. 2005 Oct;64(10):1451-5. Epub 2005 May 5.

26.

Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors.

Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, Kasagi F.

J Rheumatol. 2005 May;32(5):906-12.

PMID:
15868629
27.

Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors.

Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F, Hakoda M, Kyoizumi S, Nakachi K.

Am J Med. 2005 Jan;118(1):83-6. No abstract available.

PMID:
15639214
28.

Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.

Furuya T, Hakoda M, Tsuchiya N, Kotake S, Ichikawa N, Nanke Y, Nakajima A, Takeuchi M, Nishinarita M, Kondo H, Kawasaki A, Kobayashi S, Mimori T, Tokunaga K, Kamatani N.

J Rheumatol. 2004 Sep;31(9):1768-74.

PMID:
15338498
29.

Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.

Yang L, Hakoda M, Iwabuchi K, Takeda T, Koike T, Kamatani N, Takada K.

J Virol. 2004 Sep;78(18):9918-23.

30.

LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels.

Suzuki G, Izumi S, Hakoda M, Takahashi N.

Atherosclerosis. 2004 Sep;176(1):91-4.

PMID:
15306179
31.

Measurements of hydrodynamic diameter of AOT reverse micelles containing lipase in supercritical ethane and its enzymatic reaction.

Hakoda M, Shiragami N, Enomoto A, Nakamura K.

Bioprocess Biosyst Eng. 2003 Jan;25(4):243-7. Epub 2002 Oct 2.

PMID:
14505003
32.

[Association of serum uric acid level with cardiovascular mortality].

Hakoda M.

Nihon Rinsho. 2003 Jan;61 Suppl 1:459-64. Review. Japanese. No abstract available.

PMID:
12629766
33.

Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors.

Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, Kasagi F, Kodama K, Macphee DG, Kyoizumi S.

Int J Radiat Biol. 2003 Feb;79(2):129-36.

PMID:
12569016
35.

Microchimerism in Japanese patients with systemic sclerosis.

Ichikawa N, Kotake S, Hakoda M, Kamatani N.

Arthritis Rheum. 2001 May;44(5):1226-8. No abstract available.

36.

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.

Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N.

Arthritis Rheum. 2001 May;44(5):1003-12.

37.

T-cell responses to mitogens in atomic bomb survivors: a decreased capacity to produce interleukin 2 characterizes the T cells of heavily irradiated individuals.

Kusunoki Y, Hayashi T, Morishita Y, Yamaoka M, Maki M, Bean MA, Kyoizumi S, Hakoda M, Kodama K.

Radiat Res. 2001 Jan;155(1 Pt 1):81-8.

PMID:
11121219
38.

KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.

Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, Kamatani N, Kashiwazaki S.

J Rheumatol. 2000 May;27(5):1164-70.

PMID:
10813282
39.

[Analysis of genetic polymorphism in rheumatoid arthritis].

Hakoda M.

Ryumachi. 1999 Oct;39(5):789-98. Review. Japanese. No abstract available.

PMID:
10614176
40.

Association of HLA class I and class II alleles with myositis in Japanese patients.

Furuya T, Hakoda M, Higami K, Ueda H, Tsuchiya N, Tokunaga K, Kamatani N, Kashiwazaki S.

J Rheumatol. 1998 Jun;25(6):1109-14.

PMID:
9632072
41.

A first evidence of an asymptomatic germline missense base substitution in the hypoxanthine phosphoribosyltransferase (HPRT) gene in humans.

Fujimori S, Yamaoka N, Sakuma R, Hakoda M, Yamanaka H, Akaoka I, Kamatani N.

Adv Exp Med Biol. 1998;431:319-22. No abstract available.

PMID:
9598083
42.

The origin of APRT*J. The most common disease-related mutation of APRT gene among Japanese goes back to a prehistoric era.

Kamatani N, Terai C, Kim SY, Chen CL, Yamanaka H, Hakoda M, Totokawa S, Kashiwazaki S.

Adv Exp Med Biol. 1998;431:135-9. No abstract available.

PMID:
9598046
43.

Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment.

Yamanaka H, Togashi R, Hakoda M, Terai C, Kashiwazaki S, Dan T, Kamatani N.

Adv Exp Med Biol. 1998;431:13-8.

PMID:
9598023
44.

A germline mutation abolishing the original stop codon of the human adenine phosphoribosyltransferase (APRT) gene leads to complete loss of the enzyme protein.

Taniguchi A, Hakoda M, Yamanaka H, Terai C, Hikiji K, Kawaguchi R, Konishi N, Kashiwazaki S, Kamatani N.

Hum Genet. 1998 Feb;102(2):197-202.

PMID:
9521589
45.

Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis.

Higami K, Hakoda M, Matsuda Y, Ueda H, Kashiwazaki S.

Arthritis Rheum. 1997 Dec;40(12):2241-7.

PMID:
9416863
46.

[B cell superantigen].

Hakoda M.

Ryumachi. 1997 Aug;37(4):619-23. Review. Japanese. No abstract available.

PMID:
9311289
47.

Inactivation of food microorganisms by high-pressure carbon dioxide treatment with or without explosive decompression.

Enomoto A, Nakamura K, Nagai K, Hashimoto T, Hakoda M.

Biosci Biotechnol Biochem. 1997 Jul;61(7):1133-7.

48.

Intervention of somatic mutational events in vivo by a germline defect at the adenine phosphoribosyltransferase locus.

Hakoda M, Kamatani N, Kurumada S, Hirai Y, Sakamoto K, Yamanaka H, Terai C, Kashiwazaki S.

Hum Genet. 1997 Feb;99(2):164-70.

PMID:
9048914
49.

[APRT deficiency].

Hakoda M.

Ryoikibetsu Shokogun Shirizu. 1997;(17 Pt 2):235-8. Review. Japanese. No abstract available.

PMID:
9277905
50.

Generation and molecular characterisation of monoclonal IgG4 rheumatoid factor from a patient with rheumatoid arthritis.

Hakoda M, Kamatani N, Taniguchi A, Ueda H, Yamanaka H, Terai C, Kashiwazaki S.

Ann Rheum Dis. 1997 Jan;56(1):74-7.

Supplemental Content

Loading ...
Support Center